Showing 3361-3375 of 3756
-
‘Dark Waters’ attorney Rob Bilott works on sequel with class action lawsuit over ‘forever chemicals’
News
2 Apr 2020 | WCPO
To force companies to fund research on PFAS.
-
A focus on Canadian guidelines and guidance for contaminated sites management
Policy
1 Apr 2020
In this report, the Canadian government outlines PFAS-related programs and how they inform the development of additional environmental quality guidelines and advance contaminated site risk management.
-
Probing Mechanisms for the Tissue-Specific Distribution and Biotransformation of Perfluoroalkyl Phosphinic Acids in Common Carp (Cyprinus carpio)
Science
1 Apr 2020 | Environ. Sci. & Tech.
Perfluorohexanonate and perfluorooctanoic acids were identified in fish as metabolites after long-term exposure to PFPiAs for the first time.
-
Australian Land and Groundwater Association Webinar: PFAS and Health Outcomes
Events
1 Apr 2020
The Australian Land & Groundwater Association will be hosting a webinar over PFAS and health outcomes with speaker Dr. Alan Ducatman who was involved with the C8 Health Project in West Virginia.
-
Per- and polyfluoroalkyl substances (PFAS) differentially inhibit placental trophoblast migration and invasion in vitro
Science
1 Apr 2020 | Toxicol. Sci.
GenX found to lead to preeclampsia by inhibiting trophoblast invasion.
-
Spatiotemporal analysis of perfluoroalkyl substances in White-tailed eagle nestlings from northern Norway - a ten-year study
Science
1 Apr 2020 | Environ. Sci. Technol.
PFOS and PFHxS concentrations decreased over time, and ≥C11 perfluorinated carboxylic acids only seem to level-off during the last four years in eagle populations.
-
Perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) acutely affect human αβγ GABA receptor and spontaneous neuronal network function in vitro
Science
1 Apr 2020 | Sci Rep
PFOS found to have a clear neurotoxic risk.
-
Northeast Conference on the Science of PFAS: Public Health & the Environment
Events
31 Mar 2020
NEWMOA, in collaboration with others, has organized a conference to ensure that action to address PFAS contamination is informed by the most current and reliable science. There is also an open call for conference presenters, posters, and sponsors.
-
[Conference Talk] 3-generation study of metabolic disruption by pregnancy serum PFASs: Associations with abdominal and whole-body obesity in granddaughters in a 60-year follow-up of the child health and development studies cohort
Science
30 Mar 2020
Grandmothers with higher levels of serum PFAS (EtFOSAA) were significantly more likely to have granddaughters with obesity.
-
[Op-ed] Hazardous chemicals and government silence — a dangerous mix
News
26 Mar 2020 | The Hill
Imagine this: More than six million Americans have drinking water that is poisoned by a group of closely related chemicals.
-
Metabolic and Pharmaceutical Aspects of Fluorinated Compounds
Science
24 Mar 2020 | J of Medi. Chem.
A review of the literature associated with the metabolism of fluorinated molecules, focusing on examples where the presence of fluorine influences the metabolic profile.
-
Maternal serum perfluoroalkyl substance mixtures and thyroid hormone concentrations in maternal and cord sera: The HOME study
Science
24 Mar 2020 | Environ. Res.
PFOS had a positive trending association with thyroid-stimulating hormones.
-
Intrauterine exposure to perfluorinated compounds and overweight at age 4: A case-control study
Science
24 Mar 2020 | PLoS ONE
There was no association between PFAS exposure in early pregnancy and overweight children at age 4.
-
Exposure sources of perfluoroalkyl acids and influence of age and gender on concentrations of chlorinated polyfluorinated ether sulfonates in human serum from China.
Science
24 Mar 2020 | Environ Int
The primary source of PFCAs and PFSAs in human serum was found to be through direct exposure.
-
Characterizing biopersistence potential of the metabolite 5:3 fluorotelomer carboxylic acid after repeated oral exposure to the 6:2 fluorotelomer alcohol
Science
23 Mar 2020 | Tox. and App. Pharm.
The body transforms 6:2 FTOH into a metabolite, called 5:3 acid, that bioaccumulates, and the bioaccumulation is greater with lower exposure to 6:2 FTOH.